These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


454 related items for PubMed ID: 16242717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
    Cunha-Júnior JP, Silva DA, Silva NM, Souza MA, Souza GR, Prudencio CR, Pirovani CP, Cezar M Cascardo J, Barbosa BF, Goulart LR, Mineo JR.
    Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR, McLeod R, Mack D, Smith J, Khan IA, Ely KH, Kasper LH.
    J Immunol; 1993 May 01; 150(9):3951-64. PubMed ID: 7682587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.
    Siachoque H, Guzman F, Burgos J, Patarroyo ME, Gomez Marin JE.
    Exp Parasitol; 2006 Sep 01; 114(1):62-5. PubMed ID: 16545806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S, Vulliez-Le Normand B, Faure G, Riottot MM, Kocken CH, Thomas AW, Bentley GA.
    J Mol Biol; 2007 Mar 09; 366(5):1523-37. PubMed ID: 17229439
    [Abstract] [Full Text] [Related]

  • 11. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
    Seng S, Makala LH, Yokoyama M, Lim C, Choi YH, Suzuki N, Toyoda Y, Nagasawa H.
    Pathobiology; 2004 Mar 09; 71(3):144-51. PubMed ID: 15051927
    [Abstract] [Full Text] [Related]

  • 12. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
    Darcy F, Maes P, Gras-Masse H, Auriault C, Bossus M, Deslee D, Godard I, Cesbron MF, Tartar A, Capron A.
    J Immunol; 1992 Dec 01; 149(11):3636-41. PubMed ID: 1431132
    [Abstract] [Full Text] [Related]

  • 13. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis.
    Cardona N, de-la-Torre A, Siachoque H, Patarroyo MA, Gomez-Marin JE.
    Exp Parasitol; 2009 Oct 01; 123(2):199-202. PubMed ID: 19567250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
    Rodriguez C, Afchain D, Capron A, Dissous C, Santoro F.
    Eur J Immunol; 1985 Jul 01; 15(7):747-9. PubMed ID: 2408905
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.